Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus

Evaluation of Exclusive Breastfeeding Within the First Six Months in Infants of Mothers Infected With Novel Coronavirus: 1-year Experience of a Single Center

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04925908

Enrollment

338

Registered

2021-06-14

Start date

2021-06-01

Completion date

2021-12-31

Last updated

2022-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Exclusive, Covid19, Newborn Morbidity

Brief summary

COVID-19 pandemic emerges an issue for breastfeeding.Earlier in pandemic mothers who had COVID-19 were separated from their babies due to insufficient data but this approach was abandoned due to the lack of transmission via breastmilk.However, where mothers with COVID-19 are cohorted in the same room, they still have to be isolated from their babies following the birth.Investigators aimed to evaluate rate of exclusive breastfeeding(EB) within first 6 months among mothers who were isolated from their babies due to COVID-19.

Detailed description

COVID-19 pandemic emerges an issue for breastfeeding.Earlier in pandemic mothers who had COVID-19 were separated from their babies due to insufficient data but this approach was abandoned due to the lack of transmission via breastmilk.However, where mothers with COVID-19 are cohorted in the same room, they still have to be isolated from their babies following the birth.To our knowledge, there is no study regarding this subject to-date.Therefore, investigators aimed to evaluate rate of exclusive breastfeeding(EB) within first 6 months among mothers who were isolated from their babies due to COVID-19.

Interventions

DIAGNOSTIC_TESTRT-PCR for SARS-Cov-2

Nasopharyngeal swab for detecting Novel Coronavirus-2 by reverse transcriptase polymerase chain reaction

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

No minimum to 7 Months

Healthy volunteers

Yes

Inclusion criteria

* Infants who were born to mothers with suspected or evident COVID-19 * Accepted to participate with an informed consent of parents

Exclusion criteria

* Congenital abnormalities * Chromosomal abnormalities * Contraindication for breastfeeding * Declined to participate

Design outcomes

Primary

Measure	Time frame	Description
Exclusive breastfeeding	6 months	Rate of exclusive breastfeeding

Secondary

Measure	Time frame	Description
Disease status	6 months	COVID-19 positive/negative

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026